Comparison of bioluminescent kinase assays using substrate depletion and product formation.

Assays for ATPases have been enabled for high-throughput screening (HTS) by employing firefly luciferase to detect the remaining ATP in the assay. However, for any enzyme assay, measurement of product formation is a more sensitive assay design. Recently, technologies that allow detection of the ADP product from ATPase reactions have been described using fluorescent methods of detection. We describe here the characterization of a bioluminescent assay that employs firefly luciferase in a coupled-enzyme assay format to enable detection of ADP levels from ATPase assays (ADP-Glo, Promega Corp.). We determined the performance of the ADP-Glo assay in 1,536-well microtiter plates using the protein kinase Clk4 and a 1,352 member kinase focused combinatorial library. The ADP-Glo assay was compared to the Clk4 assay performed using a bioluminescence ATP-depletion format (Kinase-Glo, Promega Corp). We performed this analysis using quantitative HTS (qHTS) where we determined potency values for all library members and identified approximately 300 compounds with potencies ranging from as low as 50 nM to >10 microM, yielding a robust dataset for the comparison. Both assay formats showed high performance (Z'-factors approximately 0.9) and showed a similar potency distribution for the actives. We conclude that the bioluminescence ADP detection assay system is a viable generic alternative to the widely used ATP-depletion assay for ATPases and discuss the advantages and disadvantages of both approaches.

[1]  F. Fan,et al.  Bioluminescent assays for high-throughput screening. , 2007, Assay and drug development technologies.

[2]  R. Campbell,et al.  Development of a Transcreener™ Kinase Assay for Protein Kinase A and Demonstration of Concordance of Data with a Filter-Binding Assay Format , 2007, Journal of biomolecular screening.

[3]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Ching A sensitive and simple assay of starch synthase activity with pyruvate kinase and luciferase. , 1982, Analytical biochemistry.

[5]  Kim E. Garbison,et al.  The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies , 2006, Journal of biomolecular screening.

[6]  J Fraser Glickman,et al.  Scintillation proximity assays in high-throughput screening. , 2008, Assay and drug development technologies.

[7]  Peter J. Coassin,et al.  Piezo- and solenoid valve-based liquid dispensing for miniaturized assays. , 2005, Assay and drug development technologies.

[8]  R. Eglen,et al.  A Generic, Homogenous Method for Measuring Kinase and Inhibitor Activity via Adenosine 5′-Diphosphate Accumulation , 2006, Journal of biomolecular screening.

[9]  Christopher P Austin,et al.  Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS , 2009, Journal of biomolecular screening.

[10]  Christopher P Austin,et al.  High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.

[11]  J. Sportsman,et al.  A Homogeneous Fluorescence Polarization Assay Adaptable for a Range of Protein Serine/Threonine and Tyrosine Kinases , 2003, Journal of biomolecular screening.

[12]  L. Makings,et al.  A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.

[13]  P. Broad,et al.  Identification of kinase inhibitors by an ATP depletion method. , 2004, Assay and drug development technologies.

[14]  Christopher P Austin,et al.  Characterization of chemical libraries for luciferase inhibitory activity. , 2008, Journal of medicinal chemistry.

[15]  J. Hornberg,et al.  Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay. , 2009, Assay and drug development technologies.

[16]  W. Jenkins The pyruvate kinase-coupled assay for ATPases: a critical analysis. , 1991, Analytical biochemistry.

[17]  I. H. Segel Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[18]  Yue Yuan,et al.  Determining Appropriate Substrate Conversion for Enzymatic Assays in High-Throughput Screening , 2003, Journal of biomolecular screening.

[19]  Christopher P Austin,et al.  Identification of pregnane X receptor ligands using time-resolved fluorescence resonance energy transfer and quantitative high-throughput screening. , 2009, Assay and drug development technologies.

[20]  A. Bridges,et al.  A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. , 1994, Science.

[21]  Sam Michael,et al.  Compound Management for Quantitative High-Throughput Screening , 2008, JALA.

[22]  J. Sportsman,et al.  Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. , 2004, Assay and drug development technologies.

[23]  Hiroshi Kimura,et al.  Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks* , 2004, Journal of Biological Chemistry.

[24]  Christopher P Austin,et al.  A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution. , 2009, Journal of medicinal chemistry.

[25]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[26]  T. Turek-Etienne,et al.  Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. , 2003, Assay and drug development technologies.

[27]  G. Zaman,et al.  High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.

[28]  T. Spicer,et al.  Comparison of Miniaturized Time-Resolved Fluorescence Resonance Energy Transfer and Enzyme-Coupled Luciferase High-Throughput Screening Assays to Discover Inhibitors of Rho-Kinase II (ROCK-II) , 2008, Journal of biomolecular screening.

[29]  T. Misteli,et al.  Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk). , 2009, Bioorganic & medicinal chemistry letters.

[30]  R. Eglen,et al.  The current status of drug discovery against the human kinome. , 2009, Assay and drug development technologies.

[31]  P. Cleveland,et al.  Nanoliter dispensing for uHTS using pin tools. , 2005, Assay and drug development technologies.

[32]  H. Cottam,et al.  Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha. , 1999, Journal of medicinal chemistry.

[33]  D. Auld,et al.  Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. , 2003, Assay and drug development technologies.